Laobaixing Pharmacy Chain Joint Stock Co operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Laobaixing Pharmacy Chain Joint Stock Co with three other
companies in this sector in China:
HPGC Renmintongtai Pharmaceutical Corp
sales of 8.01 billion Chinese Renmimbi [US$1.27 billion]
of which 99%
was Pharmaceutical Commerce),
Yifeng Pharmacy Chain Co Ltd
(4.81 billion Chinese Renmimbi [US$765.12 million]
of which 95%
was Medicine Retail), and
CECEP Solar Energy Co Ltd
(5.20 billion Chinese Renmimbi [US$828.39 million]
of which 50%
was Solar Power Generation).
Laobaixing Pharmacy Chain Joint Stock Co reported sales of 7.50 billion Chinese Renmimbi (US$1.19 billion)
December of 2017.
increase of 23.1%
versus 2016, when the company's sales were 6.09 billion Chinese Renmimbi.
Sales at Laobaixing Pharmacy Chain Joint Stock Co have increased during each of the previous five years
(and since 2012, sales have increased a total of 164%).
Sales of Pharmaceutical Wholesale saw an increase
that was more than double the company's growth rate: sales were up
93.1% in 2017, from
291.68 million Chinese Renmimbi to 563.32 million Chinese Renmimbi.